Skip to main content

Honors & Distinctions

SFH Web Setups Logos 2020

St. Francis Hospital, The Heart Center® is New York State’s only specialty designated cardiac center, offering one of the leading cardiac care programs in the nation. A member of Catholic Health Services of Long Island, the Hospital is recognized as an innovator in the delivery of specialized cardiovascular services in an environment where excellence and compassion are emphasized.

St. Francis also offers an outstanding program in non-cardiac surgery, including some of the most advanced technology and minimally invasive techniques available for vascular, prostate, ear-nose-throat (ENT), abdominal, oncologic, and orthopedic surgery. These are some of the distinctions and accolades earned by the Hospital:
  • U.S. News & World Report has ranked St. Francis one of the best hospitals in the nation for Cardiology & Heart Surgery, Gastroenterology & GI Surgery, and Geriatrics and for the first time, Pulmonology & Lung Surgery.  We are also rated as high performing in Nephrology, Neurology & Neurosurgery, Orthopedics, and Urology. The U.S. News ratings are based on a review of nearly 5,000 hospitals nationwide. (2020-21)
  • St. Francis is also recognized by U.S. News as High Performing in nine out of ten common adult procedures and conditions: abdominal aortic aneurysm repair, aortic valve surgery, heart bypass surgery, heart failure, colon cancer surgery, COPD, hip and knee replacement, and Transcatheter Aortic Valve Replacement (TAVR). (2020-21)
  • The Hospital has been rated among the Top Ten hospitals in the region by U.S. News – ranking #8 in New York State and tying for #8 in the NY Metro Area. (2020-21)
  • St. Francis has been ranked one of the six best hospitals in the country for cardiology by Newsweek in its "The World's Best Hospital 2020" list.
  • Received an 'A' for the 15th time from the Leapfrog Group in a national safety score that rates hospitals on their quality of care. St. Francis is one of  just three hospitals on Long Island and the only one in Nassau and Queens to receive an 'A.'
  • St. Francis has achieved Magnet designation for excellence in nursing three consecutive times the only hospital in Nassau to do so.
  • St. Francis has repeatedly earned the American Stroke Association’s Get With The Guidelines Gold Plus award for Stroke care. (2019)
  • St. Francis outranks any hospital on Long Island in Patient Experience. (January 2020 - Medicare.gov)
  • The NYS Department of Health recognized St. Francis as a Top Performer in three measures aimed at preventing strokes.
  • Six of St. Francis Hospital's med-surg nursing units hold the AMSN PRISM Award for exemplary nursing practice; a national record.
  • The American Association of Critical Care Nurses (AACN) has given their prestigious Beacon Award for Excellence to every one of St. Francis Hospital’s six critical care units. (2019)
  • The American Society for Metabolic and Bariatric Surgery has designated St. Francis a nationally accredited surgical weight loss center. (2018)
  • The Cancer Institute at St. Francis Hospital is accredited by The Commission on Cancer (CoC) of the American College of Surgeons. (2018)
  • St. Francis Hospital is a leader in Transcatheter Aortic Valve Replacement (TAVR) and was one of the first hospitals in the U.S. to implant the Medtronic CoreValve. To date, St. Francis has performed about 2,000 TAVR procedures, the highest volume on Long Island.
  • The Hospital was the first on Long Island to implant the St. Jude Nanostim leadless pacemaker.
  • St. Francis was also the first hospital on Long Island to use the OCT system to visualize arterial blockages.
  • St. Francis is a recognized national leader in cardiac non-invasive imaging, including cardiac CT scanning, cardiac PET-CT scanning, cardiac magnetic resonance imaging (cardiac MRI), nuclear imaging, and three-dimensional echocardiography.
  • St. Francis is a premier center for research, participating in national clinical trials in Interventional Cardiology (Ilumien 4, Disrupt CAD III);Structural Heart for the treatment of aortic stenosis (Medtronic Low Risk TAVR Trial) and mitral valve regurgitation requiring replacement or repair (APOLLO Trial, Edwards CardiAQ, Cardioband); Heart Failure (Guide HF, Define HF, Embrace HF) and in investigator initiated trials that study the underlying mechanisms of heart disease using a full range of state-of-the-art cardiac imaging modalities.

 

Last updated: July 2020

Image

 

Share